- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Flamel Technologies SA
+ Add to WatchlistFLML:US
6.1600 USD 0.0500 0.81%As of 20:10:00 ET on 06/18/2013.
Snapshot for Flamel Technologies SA (FLML)
| Open: | 6.2500 | Day's Range: | 5.9500 - 6.2500 | Volume: | 28,436 |
|---|---|---|---|---|---|
| Previous Close: | 6.2100 | 52wk Range: | 2.8500 - 6.4000 | 1-Yr Rtn: | +50.24% |
Key Statistics for FLML
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.6300 |
| Est. EPS (USD) (12/2013) | -0.9900 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 154.97 |
| Shares Outstanding (M) | 25.16 |
| 30 Day Average Volume | 109,297 |
| Price/Book (mrq) | 5.1324 |
| Price/Sale (ttm) | 6.5004 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FLML
Company Profile & Key Executives for FLML
Flamel Technologies S.A. provides pharmaceutical products and services. The Company develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products.
| Michael S Anderson "Mike"Chief Executive Officer | Sian CrouzetPrincipal Financial Officer |
| Steven A LisiSenior VP:Bus & Corporate Dev | Rafael JordaExec VP/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FLML News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page